title: Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.
abstract: A three-dimensional (3D) integrated rotating-wall vessel cell-culture system was used to evaluate the interaction between a human prostate cancer cell line, LNCaP, and microcarrier beads alone, or microcarrier beads previously seeded with either prostate or bone stromal cells. Upon coculture of LNCaP cells with microcarrier beads either in the presence or in the absence of prostate or bone stromal cells, 3D prostate organoids were formed with the expected hormonal responsiveness to androgen, increased cell growth, and prostate-specific antigen production. In this communication, we define permanent phenotypic and genotypic changes of LNCaP cells upon coculture with microcarrier beads alone, or with microcarrier beads previously seeded with either prostate or bone stromal cells. Most notably, we observed selective genetic changes, i.e., chromosomal losses or gains, as evaluated by both conventional cytogenetic and comparative genomic hybridization, in LNCaP sublines derived from the prostate organoids. Moreover, the derivative LNCaP cells appear to have altered growth profiles, and exhibit permanent and stable changes in response to androgen, estrogen, and growth factors. The derivative LNCaP sublines showed increased anchorage-independent growth rate, and enhanced tumorigenicity and metastatic potential when inoculated orthotopically in castrated athymic mice. Our results support the hypothesis that further nonrandom genetic and phenotypic changes in prostate cancer epithelial cells can occur through an event that resembles "adaptive mutation" such as has been described in bacteria subjected to nutritional starvation. The occurrence of such permanent changes may be highly contact dependent, and appears to be driven by specific microenvironmental factors surrounding the tumor cell epithelium grown as 3D prostate organoids.
authors.affiliation: Department of Urology, University of Virginia Health Sciences Center, Charlottesville 22908, USA.
authors.forename: H W
authors.initials: HW
authors.lastname: Rhee
authors.forename: H E
authors.initials: HE
authors.lastname: Zhau
authors.forename: S
authors.initials: S
authors.lastname: Pathak
authors.forename: A S
authors.initials: AS
authors.lastname: Multani
authors.forename: S
authors.initials: S
authors.lastname: Pennanen
authors.forename: T
authors.initials: T
authors.lastname: Visakorpi
authors.forename: L W
authors.initials: LW
authors.lastname: Chung
mesh_terms: D000818:Animals; D018929:Cell Culture Techniques; D002455:Cell Division / Q000187:drug effects; D002869:Chromosome Aberrations; D002871:Chromosome Banding; D018920:Coculture Techniques; D020732:Cytogenetic Analysis; D004958:Estradiol / Q000494:pharmacology; D005838:Genotype; D006133:Growth Substances / Q000494:pharmacology; D006801:Humans; D008297:Male; D015741:Metribolone / Q000494:pharmacology; D051379:Mice; D008819:Mice, Nude; D008863:Microspheres; D009362:Neoplasm Metastasis; D009368:Neoplasm Transplantation; D010641:Phenotype; D017430:Prostate-Specific Antigen; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology*; D012399:Rotation; D017154:Stromal Cells; D014407:Tumor Cells, Cultured
chemical_list: D006133:Growth Substances; D015741:Metribolone; D004958:Estradiol; D017430:Prostate-Specific Antigen